What are the classes of CYP3A4 inhibitors?

CYP3A4 Inhibitor Classes

CYP3A4 inhibitors are categorized into several major drug classes: azole antifungals, macrolide antibiotics, HIV protease inhibitors, calcium channel blockers, antidepressants, and certain dietary components, with varying degrees of inhibitory potency. 1, 2

Strong CYP3A4 Inhibitors

Azole Antifungals

• Ketoconazole, itraconazole, voriconazole, and posaconazole are potent CYP3A4 inhibitors that can more than double plasma concentrations of CYP3A4 substrates 1, 2, 3
• These agents should be avoided in patients requiring CYP3A4-metabolized medications with narrow therapeutic indices 2

Macrolide Antibiotics

• Clarithromycin, erythromycin, and telithromycin are mechanism-based CYP3A4 inhibitors that cause NADPH-, time-, and concentration-dependent enzyme inactivation 1, 2, 4
• Clarithromycin has been associated with increased hospitalization for major bleeding when combined with DOACs 1
• Azithromycin is notably a P-glycoprotein inhibitor but has minimal CYP3A4 inhibitory effects 1

HIV Protease Inhibitors

• Ritonavir is the most potent CYP3A4 inhibitor among all protease inhibitors, followed sequentially by indinavir, nelfinavir, amprenavir, and saquinavir 1, 2
• Atazanavir, nelfinavir, saquinavir, and indinavir are also strong inhibitors 1, 2
• These agents variably inhibit CYP3A4 and can cause profound increases in substrate drug concentrations 1, 5

Calcium Channel Blockers

• Verapamil and diltiazem are moderate CYP3A4 inhibitors that also inhibit P-glycoprotein 1, 3, 4
• Verapamil is specifically noted as a moderate inhibitor with dual effects on drug transport 1

Antidepressants

• Fluoxetine, fluvoxamine, and nefazodone act as mechanism-based CYP3A4 inhibitors 3, 4, 5
• These agents cause irreversible enzyme inactivation through reactive metabolite formation 4, 6

Moderate CYP3A4 Inhibitors

Additional Agents

• Amiodarone is classified as a weak CYP3A4 inhibitor but also inhibits CYP2C9, CYP2D6, and P-glycoprotein 1
• Cyclosporine is both a CYP3A4 substrate and inhibitor 1

Dietary and Herbal Components

Grapefruit Juice

• Grapefruit juice is a potent CYP3A4 inhibitor that should be avoided with CYP3A4 substrate medications 1, 2, 3
• It increases plasma concentrations of dasatinib and other CYP3A4 substrates unpredictably 1

Herbal Components

• Bergamottin and glabridin (found in certain herbal products) act as mechanism-based CYP3A4 inhibitors 6

Clinical Implications by Strength

Strong Inhibitors (Avoid Combinations)

The National Comprehensive Cancer Network specifically recommends avoiding strong CYP3A4 inhibitors including ketoconazole, itraconazole, voriconazole, clarithromycin, telithromycin, ritonavir, nelfinavir, saquinavir, atazanavir, indinavir, and nefazodone in patients taking CYP3A4 substrate medications 2

Mechanism-Based Inhibitors (Highest Risk)

Mechanism-based inhibitors cause irreversible enzyme inactivation requiring synthesis of new CYP3A4 protein, leading to more prolonged and unpredictable drug interactions compared to reversible inhibitors 4, 6

Important Caveats

• Many CYP3A4 inhibitors also inhibit P-glycoprotein, creating dual mechanisms for drug interactions that confound prediction of clinical effects 1, 3
• The clinical significance depends on whether the affected drug has a narrow therapeutic index, steep concentration-response relationship, and individual patient factors including CYP3A4 tissue content 5
• Contraindicated combinations include CYP3A4 inhibitors with terfenadine, astemizole, cisapride, or pimozide due to risk of fatal cardiac arrhythmias 2, 5